{"entity":{"type":"insider","cik":"0001940120","url":"/insider/0001940120","json_url":"/insider/0001940120.json","name":"Lee Tien-Li","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":4,"first":"2025-02-19","last":"2025-12-12","span_basis":"filed_date"},"name_variants":[{"name":"Lee Tien-Li","source":"filing","n_filings":4,"first_seen":"2025-02-19","last_seen":"2025-12-12"}],"transactions":[{"id":4532230,"accession":"0001193125-25-318069","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-318069","line_url":"/filing/0001193125-25-318069#line-1","is_derivative":false,"issuer_cik":"0001774857","issuer_name":"Aardvark Therapeutics, Inc.","issuer_ticker":"AARD","issuer_name_source":null,"issuer_url":"/issuer/0001774857","owner_cik":"0001940120","owner_name":"Lee Tien-Li","owner_display_name":"Lee Tien-Li","owner_url":"/insider/0001940120","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":14.485,"price_display":"14.48","price_state":"stated","total_value":101395.0,"total_display":"101,395.00","total_whole":"101,395","shares_owned_after":1551613.0,"shares_owned_after_display":"1,551,613","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-11","filed_date":"2025-12-12","scope":"insider"},{"id":4672150,"accession":"0001193125-25-204233","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-204233","line_url":"/filing/0001193125-25-204233","is_derivative":false,"issuer_cik":"0001774857","issuer_name":"Aardvark Therapeutics, Inc.","issuer_ticker":"AARD","issuer_name_source":null,"issuer_url":"/issuer/0001774857","owner_cik":"0001940120","owner_name":"Lee Tien-Li","owner_display_name":"Lee Tien-Li","owner_url":"/insider/0001940120","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":9.66236,"price_display":"9.66","price_state":"stated","total_value":96623.6,"total_display":"96,623.60","total_whole":"96,624","shares_owned_after":1539884.0,"shares_owned_after_display":"1,539,884","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-15","filed_date":"2025-09-16","scope":"insider","n_lines":2},{"id":4201809,"accession":"0001193125-25-202490","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-25-202490","line_url":"/filing/0001193125-25-202490#line-3","is_derivative":false,"issuer_cik":"0001774857","issuer_name":"Aardvark Therapeutics, Inc.","issuer_ticker":"AARD","issuer_name_source":null,"issuer_url":"/issuer/0001774857","owner_cik":"0001940120","owner_name":"Lee Tien-Li","owner_display_name":"Lee Tien-Li","owner_url":"/insider/0001940120","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":8.5031,"price_display":"8.50","price_state":"stated","total_value":42515.5,"total_display":"42,515.50","total_whole":"42,516","shares_owned_after":1533384.0,"shares_owned_after_display":"1,533,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-12","filed_date":"2025-09-12","scope":"insider"},{"id":4201805,"accession":"0001193125-25-202490","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-202490","line_url":"/filing/0001193125-25-202490#line-2","is_derivative":false,"issuer_cik":"0001774857","issuer_name":"Aardvark Therapeutics, Inc.","issuer_ticker":"AARD","issuer_name_source":null,"issuer_url":"/issuer/0001774857","owner_cik":"0001940120","owner_name":"Lee Tien-Li","owner_display_name":"Lee Tien-Li","owner_url":"/insider/0001940120","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":7.821,"price_display":"7.82","price_state":"stated","total_value":46926.0,"total_display":"46,926.00","total_whole":"46,926","shares_owned_after":1528384.0,"shares_owned_after_display":"1,528,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-11","filed_date":"2025-09-12","scope":"insider"},{"id":4201801,"accession":"0001193125-25-202490","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-202490","line_url":"/filing/0001193125-25-202490#line-1","is_derivative":false,"issuer_cik":"0001774857","issuer_name":"Aardvark Therapeutics, Inc.","issuer_ticker":"AARD","issuer_name_source":null,"issuer_url":"/issuer/0001774857","owner_cik":"0001940120","owner_name":"Lee Tien-Li","owner_display_name":"Lee Tien-Li","owner_url":"/insider/0001940120","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9000.0,"shares_display":"9,000","price_per_share":7.9125,"price_display":"7.91","price_state":"stated","total_value":71212.5,"total_display":"71,212.50","total_whole":"71,213","shares_owned_after":1522384.0,"shares_owned_after_display":"1,522,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-10","filed_date":"2025-09-12","scope":"insider"},{"id":5116870,"accession":"0000950170-25-023253","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-023253","line_url":"/filing/0000950170-25-023253#line-2","is_derivative":false,"issuer_cik":"0001774857","issuer_name":"Aardvark Therapeutics, Inc.","issuer_ticker":"AARD","issuer_name_source":null,"issuer_url":"/issuer/0001774857","owner_cik":"0001940120","owner_name":"Lee Tien-Li","owner_display_name":"Lee Tien-Li","owner_url":"/insider/0001940120","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16542.0,"shares_display":"16,542","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":264672.0,"total_display":"264,672.00","total_whole":"264,672","shares_owned_after":1496175.0,"shares_owned_after_display":"1,496,175","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-14","filed_date":"2025-02-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001774857","name":"Aardvark Therapeutics, Inc.","url":"/issuer/0001774857","role":"Director, Officer (Chief Executive Officer), Ten percent owner","n_filings":4,"first_seen":"2025-02-19","last_seen":"2025-12-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001940120","retrieved_at":"2026-08-26T22:11:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}